For instance, only the minority of patients in the initial SCD-HeFT was treated with mineralocorticoid-receptor antagonists, and both in SCD-HeFT and DEFINITE, no cardiac resynchronization therapy (CRT) was used [6,26,27]. The gene discussed is NR3C2; the disease is Schnyder corneal dystrophy.